Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Acute Repetitive Seizures Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of epilepsy and need for efficient treatmnets
5.1.1.2. Increasing awareness regarding management of acute repetitive seizures
5.1.1.3. Rise in number of clinical trials in acute repetitive seizures
5.1.2. Restraints
5.1.2.1. High cost associated with diagnosing, managing, and treating seizure disorders
5.1.3. Opportunities
5.1.3.1. Introduction of effective treatment and novel drugs
5.1.3.2. Rise in approval rate for drugs for acute-repetitive-seizures
5.1.4. Challenges
5.1.4.1. Side effects of medications prescribed during acute-repetitive-seizures
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Acute Repetitive Seizures Market, by Product
6.1. Introduction
6.2. AZ-002
6.3. Diastat Rectal Gel
6.4. NRL-1
6.5. USL-261

7. Acute Repetitive Seizures Market, by End-use
7.1. Introduction
7.2. Clinics
7.3. Hospital

8. Americas Acute Repetitive Seizures Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Acute Repetitive Seizures Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Acute Repetitive Seizures Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Acorda Therapeutics, Inc.
12.1.2. Aculys Pharma, Inc.
12.1.3. Aquestive Therapeutics, Inc.
12.1.4. Bausch Health Companies Inc.
12.1.5. Epalex Corp.
12.1.6. Jazz Pharmaceuticals, Inc.
12.1.7. Lupin Limited
12.1.8. MonoSol Rx LLC
12.1.9. Neurelis, Inc.
12.1.10. Pharmanovia
12.1.11. Proximagen Limited
12.1.12. SK Biopharmaceuticals Co., Ltd.
12.1.13. UCB S.A.
12.1.14. Upsher-Smith Laboratories, Inc.
12.1.15. Veriton Pharma Ltd.
12.1.16. Xeris Biopharma Holdings, Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. ACUTE REPETITIVE SEIZURES MARKET RESEARCH PROCESS
FIGURE 2. ACUTE REPETITIVE SEIZURES MARKET SIZE, 2023 VS 2030
FIGURE 3. ACUTE REPETITIVE SEIZURES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ACUTE REPETITIVE SEIZURES MARKET DYNAMICS
FIGURE 7. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 10. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ACUTE REPETITIVE SEIZURES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. ACUTE REPETITIVE SEIZURES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ACUTE REPETITIVE SEIZURES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. ACUTE REPETITIVE SEIZURES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AZ-002, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIASTAT RECTAL GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY NRL-1, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY USL-261, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 11. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 20. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 22. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. CHINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. CHINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. INDIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. INDIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. JAPAN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. JAPAN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. THAILAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. THAILAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. DENMARK ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. EGYPT ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. FINLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ITALY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. NORWAY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. POLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. POLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. QATAR ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SPAIN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. TURKEY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. ACUTE REPETITIVE SEIZURES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 100. ACUTE REPETITIVE SEIZURES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 101. ACUTE REPETITIVE SEIZURES MARKET LICENSE & PRICING